Sökning: WFRF:(Falup Pecurariu Cristian) >
The Non-Motor Sympt...
The Non-Motor Symptoms Scale in Parkinson’s disease : Validation and use
-
- van Wamelen, Daniel J. (författare)
- King's College London,Radboud University Medical Center,King's College Hospital
-
- Martinez-Martin, Pablo (författare)
- CIBER Enfermedades Neurodegenerativas (CIBERNED)
-
- Weintraub, Daniel (författare)
- University of Pennsylvania,Philadelphia Veterans Affairs Medical Center
-
visa fler...
-
- Schrag, Anette (författare)
- University College London
-
- Antonini, Angelo (författare)
- University of Padova
-
- Falup-Pecurariu, Cristian (författare)
- Transylvania University Brasov
-
- Odin, Per (författare)
- Lund University,Lunds universitet,Restorative Parkinson Unit,Forskargrupper vid Lunds universitet,Lund University Research Groups,Central Hospital Bremerhaven
-
- Ray Chaudhuri, Kallol (författare)
- King's College Hospital,King's College London
-
visa färre...
-
(creator_code:org_t)
- 2020-09-29
- 2021
- Engelska 10 s.
-
Ingår i: Acta Neurologica Scandinavica. - : Hindawi Limited. - 0001-6314 .- 1600-0404. ; 143:1, s. 3-12
- Relaterad länk:
-
http://dx.doi.org/10... (free)
-
visa fler...
-
https://www.onlineli...
-
https://lup.lub.lu.s...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- The Non-Motor Symptoms Scale (NMSS) was developed and validated in 2007 as the first instrument for the comprehensive assessment of a range of non-motor symptoms in Parkinson's disease (PD). Thirteen years have elapsed since its introduction and extensive international validation with good psychometric attributes has been carried out. Here, we review the validation data of the NMSS and its cross-validity with other scales, and describe the key evidence derived from use of the NMSS in clinical studies. To date, over 100 clinical studies and trials have made use of it as an outcome measure, showing consistent and strong correlations between NMSS burden and health-related quality of life measures. Moreover, the scale has shown to be capable of detecting longitudinal changes in non-motor symptoms, where studies have shown differential changes over time of several of the NMSS domains. The scale has become a key outcome in several randomized clinical trials. Highlighting the prevalence and importance of non-motor symptoms to quality of life in patients with PD, the development of NMSS has also been useful in signposting clinical and biomarker based research addressing non-motor symptoms in PD.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Neurologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Neurology (hsv//eng)
Publikations- och innehållstyp
- for (ämneskategori)
- ref (ämneskategori)
Hitta via bibliotek
Till lärosätets databas